- Antoni Esteve, Ph.D., ( Spain) who is a member of the Board of Directors of Laboratorios del Dr. Esteve, S.A., one of Spain's largest pharmaceutical and chemical manufacturing companies with operations in 40 countries and a presence in more than 60.
- Cosimo Pulli , Ph.D., ( Italy) who serves as the senior executive responsible for Emerging Markets at Chiesi Farmaceutici Spa, one Italy's major pharmaceutical companies and the leader in R&D investment.
- Massimo Bonsi, ( Eastern Europe) who is the Founder and CEO of the Solartium Group based in Bucharest, Romania, and who has significant pharmaceutical industry knowledge and expertise in the Eastern European region.
- Anthony H. Wild , Ph.D., (International) the former President of Warner-Lambert's Parke-Davis global Pharmaceutical business. Currently, Dr. Wild is a member of the Board of Directors of Ranbaxy Laboratories and several privately-owned specialty pharmaceutical companies. He also is on the board of advisors of Auven Therapeutics, a pharmaceutical venture fund.
US Prescription Medical Food Company Appoints Board Of International Advisors
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.